D. E. Shaw & Co., Inc. - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 114 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$757,000
-62.9%
125,527
-77.8%
0.00%
-66.7%
Q3 2019$2,039,000
-31.8%
566,519
-49.2%
0.00%
-25.0%
Q2 2019$2,988,000
+12.5%
1,115,037
+24.3%
0.00%
+33.3%
Q1 2019$2,655,000
+267.2%
896,796
+97.2%
0.00%
+200.0%
Q4 2018$723,000
+46.7%
454,823
+239.7%
0.00%0.0%
Q3 2018$493,000
-44.5%
133,874
-57.4%
0.00%0.0%
Q2 2018$889,000
-29.1%
314,007
-7.0%
0.00%
-50.0%
Q1 2018$1,253,000
+18.4%
337,786
-8.0%
0.00%
+100.0%
Q4 2017$1,058,000
+1062.6%
367,197
+1706.4%
0.00%
Q3 2017$91,000
-21.6%
20,327
-19.5%
0.00%
Q2 2017$116,000
-86.1%
25,241
-75.4%
0.00%
-100.0%
Q3 2016$832,000
+54.6%
102,751
+48.9%
0.00%0.0%
Q2 2016$538,000
+263.5%
69,000
+258.9%
0.00%
Q1 2016$148,000
-87.7%
19,224
-82.8%
0.00%
-100.0%
Q4 2015$1,203,000
+157.1%
111,514
+64.8%
0.00%
+100.0%
Q3 2015$468,000
-66.4%
67,668
-56.9%
0.00%
-50.0%
Q2 2015$1,391,000
-0.1%
156,948
+11.1%
0.00%0.0%
Q1 2015$1,393,000
-35.1%
141,289
-19.4%
0.00%
-33.3%
Q4 2014$2,147,000
+92.2%
175,279
+56.7%
0.00%
+200.0%
Q3 2014$1,117,000
+88.0%
111,879
+42.5%
0.00%0.0%
Q2 2014$594,000
+123.3%
78,500
-3.1%
0.00%
Q1 2014$266,000
-80.8%
81,000
-80.6%
0.00%
-100.0%
Q4 2013$1,383,000
+99.3%
416,479
+81.3%
0.00%
+100.0%
Q3 2013$694,000
+530.9%
229,704
+1601.5%
0.00%
Q2 2013$110,00013,5000.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$56,305,0007.98%
BVF INC/IL 2,423,300$10,008,0002.01%
EMORY UNIVERSITY 454,102$1,875,0001.85%
DAFNA Capital Management LLC 196,500$812,0000.71%
Orbimed Advisors 13,107,200$54,133,0000.69%
RTW INVESTMENTS, LP 286,285$1,182,0000.44%
Marcus Capital, LLC 100,000$413,0000.44%
Rock Springs Capital Management LP 1,375,000$5,679,0000.38%
Spark Investment Management LLC 978,600$4,041,0000.33%
Bellevue Group AG 240,000$991,0000.20%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders